Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Chronic Heart Failure

Free Subscription 17.11.2025 2 BMJ 1 Cardiovasc Res 1 Chest 1 Circ Cardiovasc Qual Outcomes 6 Circulation 1 Coron Artery Dis 3 Eur Heart J 3 Eur J Heart Fail 3 Heart 4 J Am Coll Cardiol 21 J Card Fail 2 J Cardiol 1 J Thorac Cardiovasc Surg 1 N Engl J Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. 
   EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial.
   BMJ. 2025;391:r2388.
   PubMed        
   
   
2. ATTAR A, Mirhosseini SA, Mathur A, Dowlut S, et al
   Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
   BMJ. 2025;391:e083382.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

3. REDGRAVE RE, Booth LK, Richardson GD
   From immunosenescence to diastolic dysfunction: Tracing the senescence cascade in heart failure with preserved ejection fraction.
   Cardiovasc Res. 2025 Nov 8:cvaf220. doi: 10.1093.
   PubMed        
   
   

   
   Chest

4. YU R, Looney T, Conte L, Blickle J, et al
   A 65-Year-Old Man With Abdominal Distension and Shortness of Breath.
   Chest. 2025;168:e145-e148.
   PubMed         Abstract available
   
   

   
   Circ Cardiovasc Qual Outcomes

5. KESHVANI N, Coellar JD, Patel M, Bustillo-Rubio M, et al
   Patient Perspectives on a Polypill Strategy for Heart Failure with Reduced Ejection Fraction: A Convergent-Parallel Mixed Methods Study Embedded in a Randomized Clinical Trial.
   Circ Cardiovasc Qual Outcomes. 2025 Nov 10. doi: 10.1161/CIRCOUTCOMES.125.012834
   PubMed         Abstract available
   
   

   
   Circulation

6. PACKER M
   Conceptual Models to Explain Heart Failure With a Preserved Ejection Fraction: a Tale of Futility, Frustration, and Perhaps, Fruition.
   Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.078115.
   PubMed        
   
   
7. OKOH AK, Appiah LT, Wiafe YA, Amponsah MK, et al
   AI-Enabled Digital Auscultation for Detecting Heart Failure with Reduced Ejection Fraction in Sub-Saharan Africa: The DAMSUN-HF Study.
   Circulation. 2025 Nov 8. doi: 10.1161/CIRCULATIONAHA.125.078246.
   PubMed        
   
   
8. TARUYA A, Ota S, Shiono Y, Yamano T, et al
   Dapagliflozin Reduces Epicardial Adipose Tissue and Myocardial Fibrosis in Subclinical Heart Failure: The DAPA-EAT Trial.
   Circulation. 2025 Nov 9. doi: 10.1161/CIRCULATIONAHA.125.077630.
   PubMed        
   
   
9. ZILE MR, Borlaug BA, Kramer CM, Packer M, et al
   Response by Zile et al to Letter Regarding Article, "Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity".
   Circulation. 2025;152:e374-e375.
   PubMed        
   
   
10. ZHAO N, Li X, Wang L
    Letter by Zhao et al Regarding Article, "Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity".
    Circulation. 2025;152:e372-e373.
    PubMed        
    
    
11. LIU X, Wang Q, Li X, Yang Y, et al
    Correction to: Fast Degradation of MecciRNAs by SUPV3L1/ELAC2 Provides a Novel Opportunity to Tackle Heart Failure With Exogenous MecciRNA.
    Circulation. 2025;152:e404.
    PubMed        
    
    

    
    Coron Artery Dis

12. CHIEN LN, Chen YJ, Chang YH, Lin CF, et al
    Deciphering the incidence of heart failure following drug-eluting stent use in patients with high bleeding risk: a population-based cohort study.
    Coron Artery Dis. 2025 Nov 7. doi: 10.1097/MCA.0000000000001588.
    PubMed         Abstract available
    
    

    
    Eur Heart J

13. CREA F
    Heart failure: focus on genes, kidney, and sudden death.
    Eur Heart J. 2025;46:4449-4452.
    PubMed        
    
    
14. HABIBI H, Gatzoulis MA, Brida M
    Heart failure: terminology matters.
    Eur Heart J. 2025 Nov 7:ehaf775. doi: 10.1093.
    PubMed        
    
    
15. SCHUBERT MR, Sinner MF
    Understanding atrial cardiomyopathy: a missing link in the prevention of atrial fibrillation, heart failure, and stroke?
    Eur Heart J. 2025 Nov 6:ehaf832. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Heart Fail

16. SAVARESE G, Lindberg F, Cannata A, Adamo M, et al
    Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy.
    Eur J Heart Fail. 2025 Nov 9. doi: 10.1002/ejhf.70090.
    PubMed         Abstract available
    
    
17. CEELEN DCH, Ter Maaten JM, Voordes GHD, Cotter G, et al
    Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure.
    Eur J Heart Fail. 2025 Nov 11. doi: 10.1002/ejhf.70091.
    PubMed         Abstract available
    
    
18. RAVIKULAN R, Chavali S, Gunton JE, De Pasquale CG, et al
    Glucagon-like peptide-1 receptor agonists reduce atrial fibrillation among patients with heart failure with preserved and mildly reduced ejection fraction - a meta-analysis of randomized controlled trials.
    Eur J Heart Fail. 2025 Nov 11. doi: 10.1002/ejhf.70085.
    PubMed         Abstract available
    
    

    
    Heart

19. NAHIZ N, Jakobsen JC, Lukoschewitz JD, Doleman B, et al
    Combinations of diuretics for acute heart failure: a systematic review with network meta-analysis and trial sequential analysis.
    Heart. 2025 Nov 13:heartjnl-2025-326601. doi: 10.1136/heartjnl-2025-326601.
    PubMed         Abstract available
    
    
20. PARENTE HA, Oliveira MDSS, Cordeiro JVFA, Sforza LM, et al
    Levosimendan versus dobutamine in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
    Heart. 2025 Nov 12:heartjnl-2025-326744. doi: 10.1136/heartjnl-2025-326744.
    PubMed         Abstract available
    
    
21. WATANABE A, Miyamoto Y, Ueyama HA, Inoue K, et al
    Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulation.
    Heart. 2025 Nov 11:heartjnl-2025-326949. doi: 10.1136/heartjnl-2025-326949.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

22. PETRIE MC, Docherty KF, McMurray JJ
    What Is Heart Failure With Preserved Ejection Fraction?
    J Am Coll Cardiol. 2025;86:1950-1952.
    PubMed        
    
    
23. HALL ME, Spruiell CA, Mace HP, Hall JE, et al
    Adiposity and Heart Failure Risk: Time To Stop the "Obesity Paradox" Talk.
    J Am Coll Cardiol. 2025;86:1778-1780.
    PubMed        
    
    
24. SUN P
    Metabolic Health Status: A Critical Unaddressed Dimension in Obesity Phenotyping for Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2025 Oct 14:S0735-1097(25)07773.
    PubMed        
    
    
25. BORLAUG BA, Zile MR, Kramer CM, Packer M, et al
    Reply: Metabolic Health Status: A Critical Unaddressed Dimension in Obesity Phenotyping for Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2025 Oct 14:S0735-1097(25)07772.
    PubMed        
    
    

    
    J Card Fail

26. REDDY YNV, Gomberg-Maitland M, Kanwar MK
    Hemodynamic Inclusion Criteria for Trials of Heart Failure With Preserved Ejection Fraction, Cardiogenic Shock, and Pulmonary Arterial Hypertension.
    J Card Fail. 2025;31:1749-1753.
    PubMed        
    
    
27. KLEIN L
    Current and Future Landscape of Remote Hemodynamic Monitoring.
    J Card Fail. 2025;31:1731-1742.
    PubMed         Abstract available
    
    
28. JABR D, Pedersen R, Dahal A, Paredes-Flores M, et al
    Hemodynamic Profiles During Pulmonary Artery Pressure Sensor Implantation: Risk Stratification in Chronic Heart Failure With Reduced Ejection Fraction.
    J Card Fail. 2025;31:1621-1630.
    PubMed         Abstract available
    
    
29. LIN CH, Yan BW, Yeung V, Davison B, et al
    Cost-Effectiveness Analysis of GDMT Uptitration After Acute Decompensated Heart Failure from US and UK perspectives.
    J Card Fail. 2025 Nov 6:S1071-9164(25)00517.
    PubMed        
    
    
30. HAYWOOD HB, Ayodele I, Fonarow GC, Alhanti B, et al
    Potential Patient Eligibility for Hospital at Home for Management of Worsening Heart Failure in the United States.
    J Card Fail. 2025 Nov 7:S1071-9164(25)00470.
    PubMed        
    
    
31. HENDREN NS, Thibodeau JT
    'Patient Focus: For patients with systolic heart failure what chance does my heart have to recover?
    J Card Fail. 2025 Nov 7:S1071-9164(25)00518.
    PubMed        
    
    
32. PACKER M
    How Applicable Is the Adipokine Hypothesis Applicable to the General Population of Heart Failure and a Preserved Ejection Fraction?
    J Card Fail. 2025 Nov 8:S1071-9164(25)00991.
    PubMed        
    
    
33. MIN KH, Go AS, Parikh RV, Ambrosy AP, et al
    Clinical Characteristics, Early GDMT Initiation, and Likelihood of Heart Failure with Improved Ejection Fraction.
    J Card Fail. 2025 Nov 8:S1071-9164(25)00519.
    PubMed        
    
    
34. SHOJI S, Ikeaba U, Fonarow GC, Selvaraj S, et al
    Clinical Outcomes and Healthcare Costs in Patients Hospitalized With Heart Failure and Transthyretin Amyloid Cardiomyopathy: Findings From GWTG-HF.
    J Card Fail. 2025 Nov 8:S1071-9164(25)00508.
    PubMed         Abstract available
    
    
35. DORSEY NS, Baratto C, Prins KW, Atkins JL, et al
    Association of Moderate to Severe Tricuspid Regurgitation With Exercise Hemodynamics and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: Multicenter Study.
    J Card Fail. 2025 Nov 9:S1071-9164(25)00403.
    PubMed         Abstract available
    
    
36. VETROVSKY T, Siranec M, Frybova T, Gant I, et al
    Sustained increases in physical activity after a walking intervention in heart failure: 12-month WATCHFUL trial results.
    J Card Fail. 2025 Nov 11:S1071-9164(25)00513.
    PubMed        
    
    
37. ISATH A, Nohria A
    The Role of Hemodynamic Staging in Ambulatory Advanced Heart Failure.
    J Card Fail. 2025;31:1631-1634.
    PubMed        
    
    
38. WOLFSON AM, Ferrall J, Lam V, Hage P, et al
    Association of Hemodynamic Variables with the Risk of Heart transplant Waitlist Death and Deterioration.
    J Card Fail. 2025;31:1635-1643.
    PubMed         Abstract available
    
    
39. MIYASHITA S, Lamarche R, Abualsaud R, Oro P, et al
    Invasive Hemodynamic Predictors of Mortality in High-Output Heart Failure.
    J Card Fail. 2025;31:1648-1657.
    PubMed         Abstract available
    
    
40. YAKU H
    Reframing Risk in High-output Heart Failure: More Flow, More Problems.
    J Card Fail. 2025;31:1658-1660.
    PubMed        
    
    
41. GESSNER R, Hubner AC, Stobe S, Rudolph UM, et al
    Diagnosing HFpEF in Patients With Unexplained Dyspnea by Using Invasive Left Ventricular Pressure-Volume Loops.
    J Card Fail. 2025;31:1661-1671.
    PubMed         Abstract available
    
    
42. BRENER MI, Richter I
    Right (or Wrong) Heart Catheterization: The Limitations of Conventional Diagnostics for Heart Failure With Preserved Ejection Fraction.
    J Card Fail. 2025;31:1672-1674.
    PubMed        
    
    
43. BARATTO C, Minari S, Rao VN, Soranna D, et al
    Diagnostic Performance of Passive Leg-Raise and Low-Workload Exercise to Diagnose Heart Failure With Preserved Ejection Fraction.
    J Card Fail. 2025;31:1675-1683.
    PubMed         Abstract available
    
    
44. OMOTE K, Tada A, Harada T, Sorimachi H, et al
    Cardiac Dysfunction, Exercise Reserve, and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With an Implanted Pacemaker.
    J Card Fail. 2025;31:1684-1694.
    PubMed         Abstract available
    
    
45. BEKHUIS Y, Milani M, Falter M, L'hoyes W, et al
    Prognostic Value and Reproducibility of Simplified Noninvasive Pulmonary Artery Pressure-Flow Relationships in Exercise Echocardiography.
    J Card Fail. 2025;31:1707-1715.
    PubMed         Abstract available
    
    
46. YURKOVA I, Baudart S, Strehlow A, Brusca SB, et al
    Impella SmartAssist Technology: Practical Foundations and Clinical Management.
    J Card Fail. 2025;31:1719-1730.
    PubMed         Abstract available
    
    

    
    J Cardiol

47. OGURO F, Nishikawa Y
    An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: The BREATH(2) score: Discussion from a statistical perspective.
    J Cardiol. 2025 Nov 6:S0914-5087(25)00269-2. doi: 10.1016/j.jjcc.2025.
    PubMed        
    
    
48. HAMADA T, Kubo T, Takabayashi K, Kawai K, et al
    Associations between modes of death and physical impairment in patients with heart failure with preserved or reduced ejection fraction.
    J Cardiol. 2025 Nov 6:S0914-5087(25)00270-9. doi: 10.1016/j.jjcc.2025.
    PubMed         Abstract available
    
    

    
    J Thorac Cardiovasc Surg

49. BURCHILL LJ
    Commentary: The 60-Year Legacy of Fontan: Redefining Survival And Future Possibilities in Heart Failure.
    J Thorac Cardiovasc Surg. 2025 Nov 11:S0022-5223(25)00973.
    PubMed        
    
    

    
    N Engl J Med

50. IBANEZ B, Latini R, Rossello X, Dominguez-Rodriguez A, et al
    Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.
    N Engl J Med. 2025 Aug 30. doi: 10.1056/NEJMoa2504735.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.